4//SEC Filing
Ravina Bernard 4
Accession 0001689548-21-000009
CIK 0001689548other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:55 PM ET
Size
7.5 KB
Accession
0001689548-21-000009
Insider Transaction Report
Form 4
Ravina Bernard
Chief Medical Officer
Transactions
- Award
Common Stock
2021-02-12+24,512→ 80,533 total - Award
Stock Option (Right to Buy)
2021-02-12+65,800→ 65,800 totalExercise: $52.53Exp: 2031-02-12→ Common Stock (65,800 underlying)
Footnotes (2)
- [F1]Dr. Ravina was awarded 24,512 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest over a four-year period, with 10,412 shares vesting on February 12, 2022, 4,700 shares vesting on February 12, 2023, 4,700 shares vesting on February 12, 2024 and 4,700 shares vesting on February 12, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]The shares underlying this stock option vest over a four-year period, with 25% vesting on the one-year anniversary of the vesting commencement date of February 12, 2021 and the remaining 75% vesting in 36 equal monthly installments following such first anniversary, subject to the reporting person's continued service through each vesting date.
Documents
Issuer
Praxis Precision Medicines, Inc.
CIK 0001689548
Entity typeother
Related Parties
1- filerCIK 0001711276
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:55 PM ET
- Size
- 7.5 KB